TRIESENCE
Active substance: triamcinolone acetonide
INJECTION, SUSPENSION · TRIAMCINOLONE ACETONIDE 40 mg/mL
United StatesActive
Marketing holder: Novartis Pharmaceuticals Corporation
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- TRIAMCINOLONE ACETONIDE · 40 mg/mL
Registration
- Registration number
- 0078-0897
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- OPHTHALMIC
Sources
- product · openFDA NDC · 0078-0897 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0078-0897 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0078-0897 · Verified 2026-10-09 · open in source